DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

BI vs BPLPHARMA: Stock Comparison

BI vs BHARAT PARENTERALSUpdated 19 Aug 26, 4:08 PM ISTNSE & company filings

BHARAT PARENTERALS is the larger company by market capitalisation. BHARAT PARENTERALS shows a higher dividend yield and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BI leads 0; BPLPHARMA leads 5 of 7

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BIBPLPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹171 Cr
₹1,278 Cr
P/E RatioSame reading
—
1,029.83x
P/B RatioSame reading
—
3.85x
EPSBPLPHARMA has the higher reading
₹5.39
₹13.66 ✓
Book ValueContext only
₹31.49
₹452.09
Dividend YieldBPLPHARMA has the higher reading
0%
0.05% ✓

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
BPLPHARMA is the larger company
₹1,278 Cr vs ₹171 Cr
EPS
BPLPHARMA has higher earnings per share
₹13.66 vs ₹5.39
Dividend Yield
BPLPHARMA has a higher dividend yield
0.05% vs 0%
Qtr Sales Growth
BPLPHARMA has stronger quarterly sales growth
45.39% vs 20.36%
Qtr Profit Growth
BPLPHARMA has stronger quarterly profit growth
431.7% vs 90.7%
Net Margin
BPLPHARMA has a higher net margin
0% vs -2.36%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricBIBPLPHARMA
Live Price₹91.66₹1,881.9
Day Change-9.59%3.46%
Volume10.06 L5,812
52-Week High₹111.51₹2,295.1
52-Week Low₹51.62₹1,125.7
Distance from 52W High-17.8%-18%

Valuation

MetricBIBPLPHARMA
Market Cap₹171 Cr₹1,278 Cr
P/E Ratio—1,029.83x
P/B Ratio—3.85x
EPS₹5.39₹13.66
Book Value₹31.49₹452.09
Dividend Yield0%0.05%

Growth

MetricBIBPLPHARMA
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth20.36%45.39%
Qtr Profit Growth90.7%431.7%

Profitability & Leverage

MetricBIBPLPHARMA
ROE0.24%—
ROCE0.5%—
Net Margin-2.36%0%
Operating Margin31.53%—
Debt to Equity0.03x—

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBIBPLPHARMA
Promoter Holding30.01%67.2%▲ 0.03 pp
FII Holding0.04%0.11%
DII Holding0%1.37%▲ 0.31 pp
Public Holding69.94%31.31%▼ 0.35 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BI and BHARAT PARENTERALS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.